Predictive Value of Scoring System in Neonates with Disseminated Intravascular Coagulation
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 28
SponsorAssiut University
About this trial
The aims of this study were to investigate underlying diseases associated with neonatal DIC diagnosed on the first 28 days of life, and whether DIC score could predict mortality in neonates.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
age at enrollment from the first day of life to 28 days of life.
Neonates diagnosed as DIC.
Disqualifiers
Neonates born to mothers with ITP.
Autoimmune thrombocytopenic patients.
Trial population
The study will be conducted on neonates diagnosed as DIC based on their clinical and laboratory data. They will be recruited from NICU at Assiut University Children's Hospital from 1/1/2025 to 1/1/2026.
Trial design
Design model
Case-control
Time perspective
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
The aims of this study were to investigate underlying diseases associated with neonatal DIC diagnosed on the first 28 days of life
Time frame
from 1/1/2025 to 1/1/2026.2
whether DIC score could predict mortality in neonates
The aims of this study were to investigate underlying diseases associated with neonatal DIC diagnosed on the first 28 days of life, and whether DIC score could predict mortality in neonates.
Time frame
from 1/1/2025 to 1/1/2026.Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: